Urgent.News

What's breaking now, across thousands of outlets.

Science

Reprogramming CAR-T cell function through synthetic cytokine receptors suppresses metastatic progression of TNBC

Patient T cells modified with chimeric antigen receptors (CARs) have shown remarkable therapeutic success in previously incurable cancers. However, despite its success in hematological malignancies, CAR-T therapy has shown only modest efficacy in solid tumors. The medical field has focused on developing new molecular designs that enhance CAR-T persistence, prevent exhaustion in the tumor…

We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.

Read the original at biorxiv.org →

More in Science

More from Sunday 25 October →